JPRN-UMIN000006487已完成2 期
Multicenter phase II study of oral S-1 monotherapy in advanced colorectal cancer who have failed prior oxaliplatin and irinotecan-based therapies - Multicenter phase II study of oral S-1 monotherapy in advanced colorectal cancer who have failed prior oxaliplatin and irinotecan-based therapies <CCOG-1103 (C3-01)>
Chube Clinical Oncology Group (CCOG)0 个研究点目标入组 34 人开始时间: 2011年10月6日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Uncontrolled infection. (2)Patient with symptomatic cardiovascular disease or asymptomatic disease but have been treated (>=Grade 2 according to NCI-CTCAE ver.4). History of myocardial infarction within a year. (3)Severe lung disease. (4)Interstitial lung disease or pulmonary fibrosis. (5)Severe liver disease. (6)Severe renal failure, or urinary protein (more than 2+). (7)Previous history of severe drug-induced allergy (8)ileus, bowel obstruction (9)Uncontrolled severe complications (DM, hypertension, diarrhea, et al.). (10)History of active double cancer. (11)Massive pleural effusion or ascites that required drainage. (12)Brain metastasis (13)Pregnant women, possibly pregnant women, wishing to become pregnant, and nursing mothers. (14)Not appropriate for the study at the physician's assessment.
研究者
相似试验
招募中
2 期
Phase II study of S-1 monotherapy as 1st line chemotherapy in patients > or = 80 with advanced non-small cell lung cancerpatients >or = 80 with advanced non-small cell lung cancerJPRN-UMIN000008490Shinshu University Hospital35
已完成
不适用
A phase II trial of S-1 monotherapy for relapsed thymoma and thymic carcinoma: Okayama Lung Cancer Study Group Trial (OLCSG 1302)Thymoma/Thymic carcinomaJPRN-UMIN000009845Okayama Lung Cancer Study Group(OLCSG)30
招募中
2 期
Multicenter randomized phase II trial of S-1/ L-OHP (SOX) as an adjuvant treatment after resection of liver metastasis from colorectal carcinomaCases with liver metastasis from colorectal carcinoma, which is removed curatively and surgicallyJPRN-UMIN000004029Yokohama City University Graduate School of Medicine Gastroenterological surgery80
已完成
2 期
Phase II trial of S-1 monotherapy as adjuvant chemotherapy in triple negative breast cancer patients who did not achieve pathological complete response after neoadjuvant chemotherapyBreast cancerJPRN-UMIN000004340Kitasato University School of Medicine30
已完成
2 期
Multicenter phase II study of second-line S-1 monotherapy in patients with gemcitabine-refractory advanced biliary tract cancerGemcitabine-refractory advanced biliary tract cancerJPRN-UMIN000001614Faculty of Medicine, University of Tokyo22